A report from the Nuffield Trust has concluded that the UK is facing “constantly elevated medicine shortages,” including some antibiotics and epilepsy drugs, which are being fuelled by Brexit.
The think tank is urging the government to carry out a review of the deficiencies in the supply chain that are contributing to the problem, which has become the “new normal” since the UK left the EU four years ago and worsened in 2023.
